本文已被:浏览 628次 下载 374次
投稿时间:2022-03-22 网络发布日期:2023-01-20
投稿时间:2022-03-22 网络发布日期:2023-01-20
中文摘要: 目的基于网络药理学探讨抗支糖浆治疗咳嗽变异性哮喘(CVA)的靶点和作用机制。
方法通过中药系统药理学数据库与分析平台(TCMSP)获取抗支糖浆中主要活性成分及其相关靶点,通过在线人类孟德尔遗传数据系统(OMIM)、GeneCards数据库获取CVA相关靶点,采用Venny2.1绘制抗支糖浆靶点与CVA疾病靶点的韦恩图,采用Cytoscape3.6.1软件构建中药〖CD*2〗靶点网络,并应用STRING平台构建蛋白相互作用网络,应用R语言软件对关键靶点进行GO富集分析和KEGG通路富集分析。
结果共获得136个活性成分,160个药物与CVA相关靶点,主要活性成分为豆甾醇、β-谷固醇、槲皮素、儿茶素、木犀草素、山奈酚等。PPI网络中核心基因为蛋白激酶B(AKT1)、白细胞介素(IL)-6、半胱氨酸蛋白酶3(CASP3)、IL-1β、JUN等;GO功能富集后富集数目较多的有受体-配体活性、细胞因子受体结合、细胞因子活性、血红素结合等;KEGG富集通路分析显示抗支糖浆治疗CVA主要通路有脂质与动脉粥样硬化、糖尿病并发症中的AGE-RAGE信号通路以及IL-17信号通路、肿瘤坏死因子信号通路等为主;KEGG通路与基因之间的网络图中关联数量较多的基因主要有IL-1β、NFKBIA、IL-6、CHUK、CXCL8、JUN、CASP3等。
结论初步验证了抗支糖浆的药效基础,主要成分及靶点均显示具有较好的结合性能,可为抗支糖浆治疗CVA提供理论基础。
中文关键词: 网络药理学 抗支糖浆 咳嗽变异性哮喘;活性成分-核心靶点网络
Abstract:ObjectiveToexplorethetherapeutictargetandmechanismofKangzhiSyrupinthetreatmentofcoughvariantasthma(CVA)basedonnetworkpharmacology.
MethodsThemainactiveingredientsandrelatedtargetsinKangzhiSyrupwereobtainedthroughTraditionalChineseMedicineSystemsPharmacology(TCMSP),andCVArelatedtargetswereobtainedthroughOn-lineMendelianInheritanceinMan(OMIM)andGeneCardsdatabases.Venny2.1wasusedtodrawtheVenndiagramofKangzhiSyruptargetandCVAdiseasetarget,Cytoscape3.6.1softwarewasusedtobuildtheTraditionalChineseMedicine-targetnetwork,STRINGplatformwasusedtoconstructtheproteininteractionnetwork,andRlanguagewasusedtoperformGOenrichmentanalysisandKEGGpathwayenrichmentanalysisonkeytargets.
ResultsAtotalof136activecomponents,and160drug-targetsrelatedtoCVAwereobtained.Themainactivecomponentswerestigmasterol,β-sitosterol,quercetin,(+)-catechin,luteolin,kaempferol,etc.ThecoregenesinPPInetworkincludedAKT1,IL-6,CASP3,IL-1β,JUNetc.AfterGOfunctionenrichment,thereweremorereceptor-ligandactivity,cytokinereceptorbinding,cytokineactivity,hemebindingandsoon.KEGGpathwayenrichmentanalysisshowedthatthemainpathwaysofKangzhiSyrupinthetreatmentofCVAwerelipidandatherosclerosis,AGE-RAGEsignalingpathwayindiabeticcomplications,IL-17signalingpathway,TNFsignalingpathwayandotherpathways.ThegeneswithmoreassociationsinthenetworkmapbetweenKEGGpathwayandgenesincludedmainlyIL-1β,NFKBIA,IL-6,CHUK,CXCL8,JUN,CASP3,etc.
ConclusionThepharmacodynamicbasisofKangzhiSyrupispreliminarilyverified.Themaincomponentsandtargetsshowedgoodbindingproperties,whichcanprovideatheoreticalbasisforthetreatmentofCVAwithKangzhiSyrup.
keywords: Network pharmacology Kangzhi Syrup Cough variant asthma Active component-core target network
文章编号: 中图分类号:R256.12 R562.2+5 文献标志码:A
基金项目:国家自然科学基金(81874485);黑龙江省自然科学基金(LH2021H088);黑龙江省中医药科研项目(ZHY2020-149)
Author Name | Affiliation |
JINGWei-chao*,WANGYou-peng,LIZhu-ying,LIULu-jia,YANGYang,GUSheng-nan,LIZhi-jun | *HeilongjiangUniversityofChineseMedicine,Harbin,Heilongjiang150000,China |
引用文本:
景伟超,王有鹏,李竹英,等.抗支糖浆治疗咳嗽变异性哮喘作用机制网络药理学分析[J].中国临床研究,2023,36(1):29-33,39.
景伟超,王有鹏,李竹英,等.抗支糖浆治疗咳嗽变异性哮喘作用机制网络药理学分析[J].中国临床研究,2023,36(1):29-33,39.